Paulette Worcester
Family · Liberty, INNPI 1891764593
Payments from drug & device makers
Across 168 payments — averaging $14.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$908
- Lilly USA, LLC$179
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$132
- GSK$128
- Abbott$112
- Novo Nordisk$109
- plus $789 from 17 others
What the payments were for
- Food & beverage$2,357100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $908 |
| Lilly USA, LLC | 13 | $179 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $132 |
| GSK | 9 | $128 |
| Abbott | 7 | $112 |
| Novo Nordisk | 7 | $109 |
| Otsuka America Pharmaceutical, Inc. | 6 | $100 |
| Neurocrine Biosciences, Inc. | 5 | $92 |
| Supernus Pharmaceuticals, Inc. | 5 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $76 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Pfizer | 3 | $51 |
| Ironshore Pharmaceuticals Inc. | 3 | $48 |
| AstraZeneca | 3 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Exact Sciences | 2 | $27 |
| Lundbeck LLC | 1 | $19 |
| Tris Pharma Inc | 1 | $19 |
| Watermark Medical, Inc. | 1 | $16 |
| Corium, LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$2,357 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 94 | $96,867 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 120 | $80,529 |
| JardianceEmpagliflozin | 63 | $56,192 |
| EliquisApixaban | 35 | $40,490 |
| MounjaroTirzepatide | 29 | $32,490 |
| OxycontinOxycodone Hcl | 11 | $28,284 |
| RexultiBrexpiprazole | 17 | $25,308 |
| FarxigaDapagliflozin Propanediol | 35 | $24,812 |
| JanuviaSitagliptin Phosphate | 15 | $20,933 |
| XareltoRivaroxaban | 14 | $17,489 |
| TrulicityDulaglutide | 14 | $15,147 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 29 | $13,813 |
| Xtampza ErOxycodone Myristate | 11 | $12,568 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $10,151 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $9,986 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta, Breo Ellipta | $128 | $102,297174 claims |
| Novo NordiskOzempic | $109 | $96,86794 claims |
| Lilly USA, LLCMounjaro, Trulicity | $179 | $47,63743 claims |
| PfizerEliquis | $51 | $40,49035 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $40 | $35,65759 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $100 | $25,30817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,392 family providers in Indiana.
Other family in Liberty
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.